Role of excision repair cross‐complementation 1 expression as a prognostic marker for response to radiotherapy in early‐stage laryngeal cancer
Johung K, Rewari A, Wu H, Judson B, Contessa JN, Haffty BG, Decker RH. Role of excision repair cross‐complementation 1 expression as a prognostic marker for response to radiotherapy in early‐stage laryngeal cancer. Head & Neck 2012, 35: 852-857. PMID: 22740347, PMCID: PMC5723082, DOI: 10.1002/hed.23041.Peer-Reviewed Original ResearchConceptsERCC1 expressionOverall survivalExcision repair crossLocal controlT classificationLaryngeal cancerEarly-stage laryngeal cancerLaryngeal squamous cell carcinomaClinicopathologic risk factorsHigh ERCC1 expressionPlatinum-based chemotherapySquamous cell carcinomaWorse survivalCell carcinomaPrognostic valueStandard radiotherapyPrognostic markerRisk factorsEffective treatmentImmunohistochemical analysisTissue microarrayStage IRadiotherapy resistanceMultivariate analysisRadiotherapy